BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 8599433)

  • 1. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
    Ansai S; Koseki S; Hozumi Y; Kondo S
    Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gross cystic disease fluid protein-15 reactivity in extramammary Paget's disease with and without associated internal malignancy.
    Kohler S; Smoller BR
    Am J Dermatopathol; 1996 Apr; 18(2):118-23. PubMed ID: 8739985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spiradenoma and dermal cylindroma: comparative immunohistochemical analysis and histogenetic considerations.
    Meybehm M; Fischer HP
    Am J Dermatopathol; 1997 Apr; 19(2):154-61. PubMed ID: 9129700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringocystadenoma papilliferum of the male breast.
    Nowak M; Pathan A; Fatteh S; Fatteh S; Lopez J
    Am J Dermatopathol; 1998 Aug; 20(4):422-4. PubMed ID: 9700386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity?
    Fox SB; Cotton DW
    Am J Dermatopathol; 1992 Apr; 14(2):149-54. PubMed ID: 1566975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apocrine adenocarcinoma of the bilateral axillae.
    Yoshida A; Kodama Y; Hatanaka S; Takasaki T; Kuriwaki K; Yoshida H
    Acta Pathol Jpn; 1991 Dec; 41(12):927-32. PubMed ID: 1785351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An immunohistochemical study of cutaneous tumors using an antibody to the breast cyst fluid protein (GCDFP-15)].
    Komatsu T
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):991-7. PubMed ID: 2689727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extramammary Paget's disease--evidence for an apocrine origin. An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembryonic antigen, and keratin proteins.
    Mazoujian G; Pinkus GS; Haagensen DE
    Am J Surg Pathol; 1984 Jan; 8(1):43-50. PubMed ID: 6198933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of growth hormone-releasing hormone receptors in apocrine adnexal tumours and apocrine glands of the skin.
    Kővári B; Kocsis L; Varga E; Cserni G
    Pol J Pathol; 2018; 69(1):48-52. PubMed ID: 29895126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical studies of normal sweat glands, sweat gland tumors and extramammary Paget's diseases. II. Immunohistochemical studies of sweat gland tumors and extramammary Paget's diseases].
    Ansai S
    Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):133-46. PubMed ID: 2165191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of BCA-225 in various skin cancers.
    Ansai S; Hozumi Y; Kondo S
    J Dermatol; 1994 Jan; 21(1):20-4. PubMed ID: 8157817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perianal Paget's disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression.
    Nowak MA; Guerriere-Kovach P; Pathan A; Campbell TE; Deppisch LM
    Arch Pathol Lab Med; 1998 Dec; 122(12):1077-81. PubMed ID: 9870855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramammary Paget's disease of the perianal and perineal regions. Evidence of apocrine derivation.
    Merot Y; Mazoujian G; Pinkus G; Momtaz-T K; Murphy GF
    Arch Dermatol; 1985 Jun; 121(6):750-2. PubMed ID: 2408584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous apocrine mixed tumor: derived from the apocrine duct of the folliculo-sebaceous-apocrine unit?
    Gianotti R; Coggi A; Alessi E
    Am J Dermatopathol; 1998 Jun; 20(3):323-5. PubMed ID: 9650712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic features of pleural effusion in apocrine sweat gland carcinoma. A case report.
    Otani M; Maeda Y; Miyake Y; Miura M; Kudo M; Ebihara Y
    Acta Cytol; 2001; 45(1):74-8. PubMed ID: 11213508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular apocrine adenoma with eccrine and apocrine immunophenotypes or papillary tubular adenoma?
    Tellechea O; Reis JP; Marques C; Baptista AP
    Am J Dermatopathol; 1995 Oct; 17(5):499-505. PubMed ID: 8599457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staining of eccrine and apocrine neoplasms and metastatic adenocarcinoma with IKH-4, a monoclonal antibody specific for the eccrine gland.
    Ishihara M; Mehregan DR; Hashimoto K; Yotsumoto S; Toi Y; Pietruk T; Mehregan AH; Mehregan DA
    J Cutan Pathol; 1998 Feb; 25(2):100-5. PubMed ID: 9521499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.